WASHINGTON, D.C., June 6, 2012 – In light of the growing challenges facing the industry, the State
Medical Technology Alliance (SMTA), a network of state and regional associations of medical device
manufacturers, and MichBio is urging Congress to repeal the medical device tax.
Repealing the $30 billion medical device tax will protect and create high-wage American jobs, encourage
investment in medical technology, and maintain our global competitive leadership. The medical
technology industry is not only critical to quality health care, diagnostics, and device manufacturing but
to the creation of new jobs.
Repealing this tax on innovation will allow America’s medical device developers, who employ two
million workers nationwide, to invest in the creation of new high-wage positions and maintain America’s
global leadership in new medical technology.
“SMTA commends Congress for addressing this important issue. With passage of this vote, we can
preserve as many as 40,000 jobs and continue to invest in new medical technology,” said Stephen
Rapundalo, PhD, president and CEO of MichBio, and chair of the State Medical Technology Alliance.
“At a critical time for the U.S. economy, the new tax runs counter to our goal of domestic economic
growth. The STMA urges Congress to end the medical device excise tax,” added Dr. Rapundalo.
MichBio is Michigan’s statewide, non-profit industry association that represents the medical devices and
other bioscience sectors. With well over 200 medical device and equipment-related companies in the
state, including some Fortune 500 businesses, the sector is integral to Michigan’s economy.
“Our device companies have already taken and are continuing to pursue strategic steps to contend with
the impending device tax. Unfortunately, this has meant job layoffs and downsizing, along with the
consideration of moving manufacturing operations off-shore. The medical device tax is a job-killer for
Michigan, and the U.S., and will only ensure that this sector of the bio-industry will lose its competitive
edge,” stated Rapundalo.
MichBio is the trade association committed to driving growth in Michigan's biosciences industry and its
many sectors, including ag-biotech, food and nutrition, bio-based technologies and renewable chemicals,
industrial and environmental biotech, medical devices and equipment, pharmaceuticals and consumer
healthcare, diagnostics and research products, testing and research services, and clinical research.
MichBio members include biosciences companies, academic and research institutions, biosciences service
providers, and related organizations. For more information, visit www.michbio.org.